SUMO1 and cardiac hypertrophy: The genetic deletion of SUMO1 in experimental models increased the risk of developing atrial and ventricular septal defects [58], and the overexpression of SUMO1 through adenovirus-mediated transfection in the TAC heart failure model prevented cardiac hypertrophy and protected against heart failure development [25].